View in EDS PDF Full Text

Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages.

Saved in:
Bibliographic Details
Title: Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages.
Authors: Nersesian S; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada., Arseneau RJ; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada.; Department of Pathology, Dalhousie University, Halifax, NS, Canada., Mejia JP; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada., Lee SN; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada., Westhaver LP; Department of Pathology, Dalhousie University, Halifax, NS, Canada., Griffiths NW; Department of Pathology, Dalhousie University, Halifax, NS, Canada., Grantham SR; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada., Meunier L; Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, QC, Canada., Communal L; Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, QC, Canada., Mukherjee A; Akoya Biosciences, Menlo Park, CA, United States., Mes-Masson AM; Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, QC, Canada.; Department of Medicine, Université de Montréal, Montreal, QC, Canada., Arnason T; Department of Pathology, Dalhousie University, Halifax, NS, Canada.; Department of Pathology & Laboratory Medicine, QEII Health Sciences Centre, Nova Scotia Health (Central Zone), Halifax, NS, Canada., Nelson BH; Deeley Research Centre, British Columbia Cancer Research Institute, Victoria, BC, Canada.; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada., Boudreau JE; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada.; Department of Pathology, Dalhousie University, Halifax, NS, Canada.
Source: Frontiers in immunology [Front Immunol] 2024 Jan 22; Vol. 14, pp. 1307873. Date of Electronic Publication: 2024 Jan 22 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38318505
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nersesian+S%22">Nersesian S</searchLink>; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada.<br /><searchLink fieldCode="AU" term="%22Arseneau+RJ%22">Arseneau RJ</searchLink>; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada.; Department of Pathology, Dalhousie University, Halifax, NS, Canada.<br /><searchLink fieldCode="AU" term="%22Mejia+JP%22">Mejia JP</searchLink>; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada.<br /><searchLink fieldCode="AU" term="%22Lee+SN%22">Lee SN</searchLink>; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada.<br /><searchLink fieldCode="AU" term="%22Westhaver+LP%22">Westhaver LP</searchLink>; Department of Pathology, Dalhousie University, Halifax, NS, Canada.<br /><searchLink fieldCode="AU" term="%22Griffiths+NW%22">Griffiths NW</searchLink>; Department of Pathology, Dalhousie University, Halifax, NS, Canada.<br /><searchLink fieldCode="AU" term="%22Grantham+SR%22">Grantham SR</searchLink>; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada.<br /><searchLink fieldCode="AU" term="%22Meunier+L%22">Meunier L</searchLink>; Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Communal+L%22">Communal L</searchLink>; Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Mukherjee+A%22">Mukherjee A</searchLink>; Akoya Biosciences, Menlo Park, CA, United States.<br /><searchLink fieldCode="AU" term="%22Mes-Masson+AM%22">Mes-Masson AM</searchLink>; Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, QC, Canada.; Department of Medicine, Université de Montréal, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Arnason+T%22">Arnason T</searchLink>; Department of Pathology, Dalhousie University, Halifax, NS, Canada.; Department of Pathology & Laboratory Medicine, QEII Health Sciences Centre, Nova Scotia Health (Central Zone), Halifax, NS, Canada.<br /><searchLink fieldCode="AU" term="%22Nelson+BH%22">Nelson BH</searchLink>; Deeley Research Centre, British Columbia Cancer Research Institute, Victoria, BC, Canada.; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Boudreau+JE%22">Boudreau JE</searchLink>; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.; Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada.; Department of Pathology, Dalhousie University, Halifax, NS, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Jan 22; Vol. 14, pp. 1307873. <i>Date of Electronic Publication: </i>2024 Jan 22 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38318505
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2023.1307873
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1307873
    Titles:
      – TitleFull: Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nersesian S
      – PersonEntity:
          Name:
            NameFull: Arseneau RJ
      – PersonEntity:
          Name:
            NameFull: Mejia JP
      – PersonEntity:
          Name:
            NameFull: Lee SN
      – PersonEntity:
          Name:
            NameFull: Westhaver LP
      – PersonEntity:
          Name:
            NameFull: Griffiths NW
      – PersonEntity:
          Name:
            NameFull: Grantham SR
      – PersonEntity:
          Name:
            NameFull: Meunier L
      – PersonEntity:
          Name:
            NameFull: Communal L
      – PersonEntity:
          Name:
            NameFull: Mukherjee A
      – PersonEntity:
          Name:
            NameFull: Mes-Masson AM
      – PersonEntity:
          Name:
            NameFull: Arnason T
      – PersonEntity:
          Name:
            NameFull: Nelson BH
      – PersonEntity:
          Name:
            NameFull: Boudreau JE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 01
              Text: 2024 Jan 22
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1